Acetylated Tau Neuropathology in Sporadic and Hereditary Tauopathies

Irwin, David J., Cohen, Todd J., Grossman, Murray, Arnold, Steven E., McCarty-Wood, Elisabeth, Van Deerlin, Vivianna M., Lee, Virginia M.-Y., Trojanowski, John Q.·2013·The American Journal of Pathology
DOI 10.1016/j.ajpath.2013.04.025

Cited by (125)

Items 101–125 of 125

  1. An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration
    Madison I. J. Honey, Yanaika S. Hok‐A‐Hin, Elisabeth H. Thijssen, Katheryn A Q Cousins, Babette van der Weijden, Lisanne in ‘t Veld, Erik Stoops, Sterre C.M. de Boer, Flora Hillegonde Duits, Julie F. H. De Houwer et al. · 2026 · Nature Medicine
  2. Making tau amyloid models in vitro: a crucial and underestimated challenge
    Julien Broc, Clara Piersson, Yann Fichou · 2025 · FEBS Letters
  3. Expression of cytoskeleton proteins in hypothalamic cells in winter sleeping ground squirrels Citellus pygmaeus Pallas during hibernation
    Эмирбеков Эмирбек Зиядович, М. Э. Пашаева · 2014 · Neurochemical Journal
  4. Antemortem network analysis of spreading pathology in autopsy-confirmed frontotemporal degeneration
    Min Chen, Sarah Burke, Christopher A. Olm, David John Irwin, Lauren M. Massimo, Edward B. Lee, John Q. Trojanowski, James C. Gee, Murray Grossman · 2023 · Brain Communications
  5. Acetylation of tubulin: A feasible protective target from neurodevelopment to neurodegeneration
    Cappelletti Graziella, Daniele Cartelli · 2019 · Elsevier eBooks
  6. Antisense Oligonucleotide-Mediated Reduction of HDAC6 Does Not Reduce Tau Pathology in P301S Tau Transgenic Mice
    Antonio Valencia, Veronica L. Reinhart Bieber, Bekim Bajrami, Galina Marsh, Stefan Hamann, Ru Wei, Karen Ling, Frank Rigo, H. Moore Arnold, Olga Golonzhka et al. · 2021 · Frontiers in Neurology
  7. Targeted tau protein degradation: a promising therapeutic approach for tauopathies
    Narjes Baazaoui, Mohammad Yahya Alfaifi, Ali Abdullah Shati, Rania Ben Saad, Stefanıa Garzoli · 2025 · Neuroscience
  8. A Case of Early-Onset Alzheimer’s Disease Mimicking Schizophrenia in a Patient with Presenilin 1 Mutation (S170P)
    Hang‐Rai Kim, Ja Hyun Jang, Hong-Gi Ham, Seung Ho Choo, Jeong-Ho Park, Sung Hoon Kang, Song Hwangbo, Hyemin Jang, Duk Lyul Na, Sang Won Seo et al. · 2021 · Journal of Alzheimer s Disease
  9. Long-term gabapentin treatment impairs cognitive function in aged mice via tau hyperphosphorylation
    Suyun Xia, Zerong You, Xinbo Wu, Jinsheng Yang, Shiyu Wang, Na Li, Jiajia Dai, Yuanlin Dong, Lucy L Chen, Min Yan et al. · 2025 · Frontiers in Pharmacology
  10. Post-translational modifications as a regulatory code for tau function in health and disease
    Abigail J. Nordbeck, Bhirisha Sharma, Charles A. Garcia, Jui‐Heng Tseng · 2026 · Frontiers in Dementia
  11. Frontotemporal lobar degeneration
    Boram Kim, Ashley Viera-Ortiz, Jessica M. Phan, David John Irwin, Edward B. Lee · 2022 · Elsevier eBooks
  12. Impact of Lysine Acetylation Mutations on the Structure of Full-Length Tau Fibrils
    Aurelio James Dregni, Mei Hong · 2025 · ACS Chemical Neuroscience
  13. On the potential roles of TDP-43 in the formation of membraneless organelles and their transformation into toxic aggregates
    Olga S. Sergeeva, Margarita V. Neklesova, Vladislav A. Reushev, Alexey V. Artemov, Туроверов Константин Константинович, Туроверов Константин Константинович, Vladimir Nikolaevich Uversky, Alexander V. Fonin · 2025 · Biochemical and Biophysical Research Communications
  14. Tau, Tangles and Tauopathies: Insights from Drosophila Disease Models
    Nisha Nisha, Pragati, Shweta Tandon, Aqsa Aqsa, Prerna Aggarwal, Surajit Sarkar · 2019 · Springer eBooks
  15. Engineering antibody therapeutics and cell culture models for neurodegenerative diseases
    Kyle P. McHugh · 2024 · Library, Museums and Press - UDSpace (University of Delaware)
  16. Three-Repeat Tau with Grain-Like Structures and Distribution in an 83-Year-Old Man
    Naoki Kasahata, Tomohide Sato, Iichiroh Onishi, Masanobu Kitagawa, Toshiki Uchihara, Katsuiku Hirokawa · 2017 · Journal of Alzheimer s Disease
  17. The role of tau in Alzheimer’s Disease: Effects of Lys-280 and Lys-281 acetylation on tau function and structure
    Brian H. Constance · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  18. The Role of Microglial-Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) in Neuronal Homeostasis and Tau Pathogenesis
    Vaishnavi Jadhav · 2021 · IUScholarWorks (Indiana University)
  19. Posttranslational modifications of TDP-43
    Samir Rahman · 2021 · Elsevier eBooks
  20. The MAPT p.P301L mutation presents as a rare early-onset corticobasal syndrome: A case report
    Cheng‐Hsuan Li, Ni‐Chung Lee, Kun‐Ju Lin, Ing‐Tsung Hsiao, Yi-Hsin Weng, Chin‐Hsien Lin · 2023 · Neurology Asia
  21. Copy number variations of proteins associated with neurodegenerative diseases and rare neurological disorders
    Zhangzhong Yang, Peng Lei · 2024 · Scientia Sinica Vitae
  22. Liquid–liquid phase separation of tau in Alzheimer’s disease
    Sangita Rajkhowa, Timir Tripathi · 2026 · International review of neurobiology
  23. Identification et caractérisation des modifications post-traductionnelles de la protéine TAU : implication dans le processus d'agrégation
    Amina Kamah · 2015 · theses.fr (ABES)
  24. Neurotoxicité précoce et mécanismes de neuroprotection dans des modèles poisson‐zèbre de tauopathies
    Clément Barbereau · 2020 · theses.fr (ABES)
  25. Mapping the Landscape of Tau Post-translational Modifications and Kinase-Specific Phosphorylation Signatures by Orthogonal CZE-MS/MS and NanoRPLC-MS/MS
    Reyhane Tabatabaeian Nimavard, Seyed Amirhossein Sadeghi, Jorge A. Colón-Rosado, Yifan Yue, Fei Fang, Hsiao‐Tien Chien Hagar, Min-Hao Kuo, Liangliang Sun · 2026 · Journal of Proteome Research